Perfusion Blog

extracorporeal life support


Sep, 2016

Excellence in Extracorporeal Life Support Awarded to NYC Hospitals

By: | Tags: | Comments: 0

The Center for Acute Respiratory Failure and Cardiac ECMO Program at NewYork-Presbyterian/Columbia University Irving Medical Center and the Pediatric ECMO Program at NewYork-Presbyterian/Morgan Stanley Children's Hospital have been designated a Platinum Level Center of Excellence for the Excellence in Life Support Award from the Extracorporeal Life Support Organization (ELSO, an international non-profit consortium dedicated to the development of novel therapies for people with organ failure). Worldwide, only five extracorporeal life…

Abided Impella


Mar, 2016

FDA likely to approve expanded indication of Abiomed’s Impella heart pump: SEC filing

By: | Tags: , | Comments: 0

Abiomed ($ABMD) revealed in an SEC filing that the FDA has agreed to forgo an advisory panel meeting to discuss an expanded indication for its Impella 2.5, Impella CP, Impella 5.0 and Impella LD heart pumps, meaning permission to use the devices on emergency patients suffering from cardiogenic shock is a near certainty, and should occur before the previously expected date of August 2016. The news means the devices are…



Mar, 2016

Hemovent is developing the world’s smallest and first self-contained and fully portable ECMO system

By: | Tags: , | Comments: 1

Hemovent Raises $6 Million in Series A Funding February 10, 2016 09:55 AM Eastern Standard Time AACHEN, Germany--(BUSINESS WIRE)--Hemovent GmbH, an emerging medical device company, announced today that it has closed a $6 million Series A investment. Hemovent is developing the world’s smallest and first self-contained and fully portable Extra Corporeal Membrane Oxygenation (ECMO) system that supports or replaces heart and lung function in the event of cardiac and respiratory…